Works matching AU Thorens, Bernard

Results: 112
    1

    Deletion of Sirt3 does not affect atherosclerosis but accelerates weight gain and impairs rapid metabolic adaptation in LDL receptor knockout mice: implications for cardiovascular risk factor development.

    Published in:
    Basic Research in Cardiology, 2014, v. 109, n. 1, p. 1, doi. 10.1007/s00395-013-0399-0
    By:
    • Winnik, Stephan;
    • Gaul, Daniel;
    • Preitner, Frédéric;
    • Lohmann, Christine;
    • Weber, Julien;
    • Miranda, Melroy;
    • Liu, Yilei;
    • Tits, Lambertus;
    • Mateos, José;
    • Brokopp, Chad;
    • Auwerx, Johan;
    • Thorens, Bernard;
    • Lüscher, Thomas;
    • Matter, Christian
    Publication type:
    Article
    2

    Characterization of pancreatic NMDA receptors as possible drug targets for diabetes treatment.

    Published in:
    Nature Medicine, 2015, v. 21, n. 4, p. 363, doi. 10.1038/nm.3822
    By:
    • Marquard, Jan;
    • Otter, Silke;
    • Welters, Alena;
    • Stirban, Alin;
    • Fischer, Annelie;
    • Eglinger, Jan;
    • Herebian, Diran;
    • Kletke, Olaf;
    • Klemen, Maša Skelin;
    • Stožer, Andraž;
    • Wnendt, Stephan;
    • Piemonti, Lorenzo;
    • Köhler, Martin;
    • Ferrer, Jorge;
    • Thorens, Bernard;
    • Schliess, Freimut;
    • Rupnik, Marjan Slak;
    • Heise, Tim;
    • Berggren, Per-Olof;
    • Klöcker, Nikolaj
    Publication type:
    Article
    3

    SLC2A9 (GLUT9) mediates urate reabsorption in the mouse kidney.

    Published in:
    Pflügers Archiv: European Journal of Physiology, 2018, v. 470, n. 12, p. 1739, doi. 10.1007/s00424-018-2190-4
    By:
    • Auberson, Muriel;
    • Stadelmann, Sophie;
    • Stoudmann, Candice;
    • Seuwen, Klaus;
    • Koesters, Robert;
    • Thorens, Bernard;
    • Bonny, Olivier
    Publication type:
    Article
    4
    5
    6
    7

    Chronic hyperglycaemia increases the vulnerability of the hippocampus to oxidative damage induced during post-hypoglycaemic hyperglycaemia in a mouse model of chemically induced type 1 diabetes.

    Published in:
    Diabetologia, 2023, v. 66, n. 7, p. 1340, doi. 10.1007/s00125-023-05907-6
    By:
    • McNeilly, Alison D.;
    • Gallagher, Jennifer R.;
    • Evans, Mark L.;
    • de Galan, Bastiaan E.;
    • Pedersen-Bjergaard, Ulrik;
    • Thorens, Bernard;
    • Dinkova-Kostova, Albena T.;
    • Huang, Jeffrey-T.;
    • Ashford, Michael L. J.;
    • McCrimmon, Rory J.
    Publication type:
    Article
    8
    9

    Protective role of the ELOVL2/docosahexaenoic acid axis in glucolipotoxicity-induced apoptosis in rodent beta cells and human islets.

    Published in:
    Diabetologia, 2018, v. 61, n. 8, p. 1780, doi. 10.1007/s00125-018-4629-8
    By:
    • Bellini, Lara;
    • Campana, Mélanie;
    • Rouch, Claude;
    • Chacinska, Marta;
    • Bugliani, Marco;
    • Meneyrol, Kelly;
    • Hainault, Isabelle;
    • Lenoir, Véronique;
    • Denom, Jessica;
    • Véret, Julien;
    • Kassis, Nadim;
    • Thorens, Bernard;
    • Ibberson, Mark;
    • Marchetti, Piero;
    • Blachnio-Zabielska, Agnieszka;
    • Cruciani-Guglielmacci, Céline;
    • Prip-Buus, Carina;
    • Magnan, Christophe;
    • Le Stunff, Hervé
    Publication type:
    Article
    10
    11
    12
    13

    In vivo and in vitro characterization of GL0034, a novel long‐acting glucagon‐like peptide‐1 receptor agonist.

    Published in:
    Diabetes, Obesity & Metabolism, 2022, v. 24, n. 11, p. 2090, doi. 10.1111/dom.14794
    By:
    • Jones, Ben;
    • Burade, Vinod;
    • Akalestou, Elina;
    • Manchanda, Yusman;
    • Ramchunder, Zenouska;
    • Carrat, Gaëlle;
    • Nguyen‐Tu, Marie‐Sophie;
    • Marchetti, Piero;
    • Piemonti, Lorenzo;
    • Leclerc, Isabelle;
    • Thennati, Rajamannar;
    • Vilsboll, Tina;
    • Thorens, Bernard;
    • Tomas, Alejandra;
    • Rutter, Guy A.
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21

    Bioinformatics-Driven Identification and Examination of Candidate Genes for Non-Alcoholic Fatty Liver Disease.

    Published in:
    PLoS ONE, 2011, v. 6, n. 1, p. 1, doi. 10.1371/journal.pone.0016542
    By:
    • Banasik, Karina;
    • Justesen, Johanne M.;
    • Hornbak, Malene;
    • Krarup, Nikolaj T.;
    • Gjesing, Anette P.;
    • Sandholt, Camilla H.;
    • Jensen, Thomas S.;
    • Grarup, Niels;
    • Andersson, Åsa;
    • Jørgensen, Torben;
    • Witte, Daniel R.;
    • Sandbæk, Annelli;
    • Lauritzen, Torsten;
    • Thorens, Bernard;
    • Brunak, Søren;
    • Sørensen, Thorkild I. A.;
    • Pedersen, Oluf;
    • Hansen, Torben
    Publication type:
    Article
    22
    23

    LKB1 and AMPK differentially regulate pancreatic β-cell identity.

    Published in:
    FASEB Journal, 2014, v. 28, n. 11, p. 4972, doi. 10.1096/fj.14-257667
    By:
    • Kone, Marina;
    • Pullen, Timothy J.;
    • Gao Sun;
    • Ibberson, Mark;
    • Martinez-Sanchez, Aida;
    • Sayers, Sophie;
    • Nguyen-Tu, Marie-Sophie;
    • Kantor, Chase;
    • Swisa, Avital;
    • Dor, Yuval;
    • Gorman, Tracy;
    • Ferrer, Jorge;
    • Thorens, Bernard;
    • Reimann, Frank;
    • Gribble, Fiona;
    • McGinty, James A.;
    • Lingling Chen;
    • French, Paul M.;
    • Birzele, Fabian;
    • Hildebrandt, Tobias
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42

    GLP-1 metabolite GLP-1(9–36) is a systemic inhibitor of mouse and human pancreatic islet glucagon secretion.

    Published in:
    Diabetologia, 2024, v. 67, n. 3, p. 528, doi. 10.1007/s00125-023-06060-w
    By:
    • Gandasi, Nikhil R.;
    • Gao, Rui;
    • Kothegala, Lakshmi;
    • Pearce, Abigail;
    • Santos, Cristiano;
    • Acreman, Samuel;
    • Basco, Davide;
    • Benrick, Anna;
    • Chibalina, Margarita V.;
    • Clark, Anne;
    • Guida, Claudia;
    • Harris, Matthew;
    • Johnson, Paul R. V.;
    • Knudsen, Jakob G.;
    • Ma, Jinfang;
    • Miranda, Caroline;
    • Shigeto, Makoto;
    • Tarasov, Andrei I.;
    • Yeung, Ho Yan;
    • Thorens, Bernard
    Publication type:
    Article
    43
    44
    45
    46
    47

    GLP-1 receptor agonists synergize with DYRK1A inhibitors to potentiate functional human β cell regeneration.

    Published in:
    Science Translational Medicine, 2020, v. 12, n. 530, p. 1, doi. 10.1126/scitranslmed.aaw9996
    By:
    • Ackeifi, Courtney;
    • Wang, Peng;
    • Karakose, Esra;
    • Manning Fox, Jocelyn E.;
    • González, Bryan J.;
    • Liu, Hongtao;
    • Wilson, Jessica;
    • Swartz, Ethan;
    • Berrouet, Cecilia;
    • Li, Yansui;
    • Kumar, Kunal;
    • MacDonald, Patrick E.;
    • Sanchez, Roberto;
    • Thorens, Bernard;
    • DeVita, Robert;
    • Homann, Dirk;
    • Egli, Dieter;
    • Scott, Donald K.;
    • Garcia-Ocaña, Adolfo;
    • Stewart, Andrew F.
    Publication type:
    Article
    48
    49
    50